You are here
Globus Medical Supporting Resident and Surgeon Education Workshops at OTA 2018
AUDUBON, Pa., Oct. 17, 2018 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, announced today participation in Educational Workshops at the Orthopedic Trauma Association Annual Meeting October 17th- 20th in Orlando Florida.
During the resident workshops from October 17th- 19th, Globus Medical will support educational sessions entitled, Trimalleolar Ankle Fracture with Unstable Syndesmosis and External Fixation of a Comminuted Pilon Fracture, featuring the ANTHEM® Ankle Fracture System and ARBOR® External Fixation System.
The ANTHEM® Ankle Fracture System is a comprehensive set of low profile, anatomically-contoured plates for treatment of a variety of ankle fractures. A specialized set of instruments facilitates the efficiency in the operating room, with ankle-specific clamps designed to aid in fracture reduction. Radiolucent retractors and Weitlaners aid in visibility of the fracture site during intraoperative imaging.
The ARBOR® External Fixation System provides a streamlined set of clamps, pins, and bars with innovative instruments that allow surgeons to quickly create the pin-bar frame of their choice. The system offers a one-clamp design for every procedure regardless of pin size.
On Friday, October 19th, Globus will support another surgeon education workshop entitled Proximal Humerus Plating Tips and Tricks featuring the ANTHEM® Proximal Humerus Fracture System.
The ANTHEM® Proximal Humerus Fracture System is designed to treat a wide variety of shoulder fractures and streamline procedural flow during fracture fixation. The unique polyaxial screw technology allows surgeons to target dense calcar bone and enhance fixation, independent of plate position. This comprehensive, stand-alone system includes small fragment instruments and innovative retractors to aid in visibility of the fracture site, and potentially reduce surgical time.
“Globus is pleased to support the OTA in training the surgeon community and residents using the latest techniques and technology,” says Barclay Davis, Vice President, Orthopedic Trauma. “We are committed to innovation and advancement of our trauma portfolio, to streamline procedures for surgeons and improve patient care.”
To learn more about the complete line of Globus Medical trauma products visit booth #917 at OTA in Orlando, Florida.
About Globus Medical, Inc.
Globus Medical, Inc. is a leading musculoskeletal solutions company based in Audubon, PA. The company was founded in 2003 by an experienced team of professionals with a shared vision to create products that enable surgeons to promote healing in patients with musculoskeletal disorders. Additional information can be accessed at http://www.globusmedical.com.
Safe Harbor Statements
All statements included in this press release other than statements of historical fact are forward-looking statements and may be identified by their use of words such as “believe,” “may,” “might,” “could,” “will,” “aim,” “estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan” and other similar terms. These forward-looking statements are based on our current assumptions, expectations and estimates of future events and trends. Forward-looking statements are only predictions and are subject to many risks, uncertainties and other factors that may affect our businesses and operations and could cause actual results to differ materially from those predicted. These risks and uncertainties include, but are not limited to, factors affecting our quarterly results, our ability to manage our growth, our ability to sustain our profitability, demand for our products, our ability to compete successfully (including without limitation our ability to convince surgeons to use our products and our ability to attract and retain sales and other personnel), our ability to rapidly develop and introduce new products, our ability to develop and execute on successful business strategies, our ability to successfully integrate the operations of Nemaris and retain key employees, our ability to comply with changing laws and regulations that are applicable to our businesses, our ability to safeguard our intellectual property, our success in defending legal proceedings brought against us, trends in the medical device industry, general economic conditions, and other risks. For a discussion of these and other risks, uncertainties and other factors that could affect our results, you should refer to the disclosure contained in our most recent annual report on Form 10-K filed with the Securities and Exchange Commission, including the sections labeled “Risk Factors” and “Cautionary Note Concerning Forward-Looking Statements,” and in our Forms 10-Q, Forms 8-K and other filings with the Securities and Exchange Commission. These documents are available at www.sec.gov. Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for us to predict all risk factors and uncertainties, nor can we assess the impact of all factors on its business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. Given these risks and uncertainties, readers are cautioned not to place undue reliance on any forward-looking statements. Forward-looking statements contained in this press release speak only as of the date of this press release. We undertake no obligation to update any forward-looking statements as a result of new information, events or circumstances or other factors arising or coming to our attention after the date hereof.
Vice President, Business Development and Investor Relations
Phone: (610) 930-1800